V

Vaxcell Bio Therapeutics
KOSDAQ:323990

Watchlist Manager
Vaxcell Bio Therapeutics
KOSDAQ:323990
Watchlist
Price: 9 410 KRW -2.79% Market Closed
Market Cap: 218.9B KRW

Vaxcell Bio Therapeutics
Investor Relations

Vaxcell-Bio Therapeutics develops anti-cancer therapeutics. The company is headquartered in Hwasun, Jeollanam-Do and currently employs 47 full-time employees. The company went IPO on 2020-09-22. The firm's pipeline consists of the Vax-NK natural killer cell anti-cancer immunotherapy platforms, the Vax-DC dendritic cell anti-cancer immunotherapy platforms, and the Vax-CAR series next-generation advanced anti-cancer immunotherapy platforms. In addition, the Company manufactures and sells cytokine-based boxleukin-15, an anticancer immunotherapy exclusively for dogs. The firm sells its products in domestic and overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
JEOLLANAM-DO
Hwasun
1F, Biomaterials Incubation Center, 12-55, Sandan-gil, Hwasun-eup
Contacts